Validated clinical efficacy and scalable manufacturing propel exosomes from research discovery to commercial therapeutics.
With a growing number of exosome-based delivery vehicles advancing into the clinic for therapeutics and vaccines, more effective isolation and separation strategies are needed. Finnish researchers ...
HIV hijacks SRRM2 to enlarge nuclear speckles, stabilizing CPSF6 puncta and promoting efficient viral replication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback